Sanofi
SAN
Real-time Euronext Paris - 07/19 05:35:05 pm
72.11EUR
-0.55%
Prev.72.5100
Open72.3000
High72.4600
Low71.9500
Volume2 292 087
Financials
Sales 2018 35 048 M
EBIT 2018 8 298 M
R. net 2018 5 080 M
Debt 2018 15 904 M
Rend. 2018 4,15%
P/E ratio 2018 17,42
P/E ratio 2019 16,27
EV / Sales 2018 3,03x
EV / Sales 2019 2,86x
Capitalization 90 118 M
Company
Sanofi engages in the research, production and distribution of pharmaceutical products.It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Human Vaccines.The Pharmaceuticals segment comprises the commercial operations of the following global franchises:...
Sector :
Pharmaceuticals - NEC
Calendar :
2018-07-31 Earnings Release
Trading Rating :
Investor Rating :
Latest news
01:25pSANOFI : NAD Recommends Chattem Discontinue 'Twice As Fast' Claim for Xyzal Following Challenge From Claritin Maker Bayer HealthCare
AQ
10:31aSANOFI : Revolution scores $500M Sanofi deal on first oncology program
AQ
10:29aSANOFI : bags rights to Revolutions SHP2 cancer drug
AQ
10:29aSANOFI : pays $50 million for Revolution Medicines SHP2 inhibitor
AQ
07/18SANOFI : Revolution, Sanofi partner on SHP-2 inhibitors for cancer
AQ
07/18CanSino latest to file for HKEX IPO
AQ
07/17SANOFI : 11th Dengvaxia complaint filed vs. Garin, 36 others
AQ
07/17SANOFI : NBI files raps in Ombudsman vs. Aquino, others over Dengvaxia mess
AQ
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralBearish
Resistance73,573,574,4
Spread/Res.-1,9%-1,9%-3,0%
Spread/Supp.4,2%14%14%
Support69,263,263,4